C. Fitzgerald

发表

Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer: a population-based study.

H. Kennecke, S. Gill, B. Melosky, 2007, Journal of oncology practice.

Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting.

L. Sehn, J. Connors, J. Spinelli, 2007, Blood.

Rapid Infusion Rituximab in Combination with Steroid Containing Chemotherapy Can Be Given Safely and Substantially Reduces Resource Utilization.

L. Sehn, J. Connors, J. Spinelli, 2004 .

CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma (DLBCL).

R. Gascoyne, L. Sehn, J. Connors, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Therapy with Raltitrexed in Patients with Colorectal Cancer Intolerant of 5-Fluorouracil: British Columbia Cancer Agency Experience

S. Gill, B. Pharm., K. Wilson, 2007, Cancer investigation.

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.

R. Gascoyne, L. Sehn, J. Connors, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

R. Gascoyne, L. Sehn, J. Connors, 2007, Blood.

CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma

R. Gascoyne, L. Sehn, J. Connors, 2007, Leukemia & lymphoma.

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

R. Gascoyne, L. Sehn, J. Connors, 2005 .

Improvements in 5-year Outcomes of Stage II/III Rectal Cancer Relative to Colon Cancer

H. Kennecke, R. Woods, D. Renouf, 2013, American journal of clinical oncology.

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

R. Gascoyne, L. Sehn, J. Connors, 2007 .

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

R. Gascoyne, L. Sehn, J. Connors, 2007, Blood.